Cite
HARVARD Citation
Xu, H. et al. (2020). Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants. Cancer medicine. pp. 3328-3336. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xu, H. et al. (2020). Crizotinib vs platinum‐based chemotherapy as first‐line treatment for advanced non‐small cell lung cancer with different ROS1 fusion variants. Cancer medicine. pp. 3328-3336. [Online].